{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:13:01Z","timestamp":1772136781622,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Axsome Therapeutics"},{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s12325-022-02249-4","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T18:02:37Z","timestamp":1659636157000},"page":"4359-4373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Solriamfetol Titration and AdministRaTion (START) in Patients with Obstructive Sleep Apnea: A Retrospective Chart Review and Hypothetical Patient Scenario"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2710-1384","authenticated-orcid":false,"given":"Haramandeep","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5669-7121","authenticated-orcid":false,"given":"Danielle","family":"Hyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4695-1955","authenticated-orcid":false,"given":"Gregory S.","family":"Parks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abby","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0603-4995","authenticated-orcid":false,"given":"Catherine","family":"Foley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Baldys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1396-7395","authenticated-orcid":false,"given":"Diane","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3993-2230","authenticated-orcid":false,"given":"Michael J.","family":"Thorpy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"issue":"8","key":"2249_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/s2213-2600(19)30198-5","volume":"7","author":"AV Benjafield","year":"2019","unstructured":"Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687\u201398. https:\/\/doi.org\/10.1016\/s2213-2600(19)30198-5.","journal-title":"Lancet Respir Med"},{"key":"2249_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3389\/fneur.2018.00505","volume":"9","author":"S Garbarino","year":"2018","unstructured":"Garbarino S, Scoditti E, Lanteri P, Conte L, Magnavita N, Toraldo DM. Obstructive sleep apnea with or without excessive daytime sleepiness: clinical and experimental data-driven phenotyping. Front Neurol. 2018;9:505. https:\/\/doi.org\/10.3389\/fneur.2018.00505.","journal-title":"Front Neurol"},{"issue":"1","key":"2249_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/sleep\/34.1.111","volume":"34","author":"NA Antic","year":"2011","unstructured":"Antic NA, Catcheside P, Buchan C, et al. The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA. Sleep. 2011;34(1):111\u20139.","journal-title":"Sleep"},{"issue":"4","key":"2249_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/jsr.12039","volume":"22","author":"M Gasa","year":"2013","unstructured":"Gasa M, Tamisier R, Launois SH, et al. Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure. J Sleep Res. 2013;22(4):389\u201397. https:\/\/doi.org\/10.1111\/jsr.12039.","journal-title":"J Sleep Res"},{"issue":"5","key":"2249_CR5","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1183\/09031936.00016808","volume":"33","author":"JL Pepin","year":"2009","unstructured":"Pepin JL, Viot-Blanc V, Escourrou P, et al. Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study. Eur Respir J. 2009;33(5):1062\u20137. https:\/\/doi.org\/10.1183\/09031936.00016808.","journal-title":"Eur Respir J"},{"issue":"3","key":"2249_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5664\/jcsm.27497","volume":"5","author":"LJ Epstein","year":"2009","unstructured":"Epstein LJ, Kristo D, Strollo PJ Jr, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5(3):263\u201376.","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"2249_CR7","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.chest.2020.02.036","volume":"158","author":"S Javaheri","year":"2020","unstructured":"Javaheri S, Javaheri S. Update on persistent excessive daytime sleepiness in OSA. Chest. 2020;158(2):776\u201386. https:\/\/doi.org\/10.1016\/j.chest.2020.02.036.","journal-title":"Chest"},{"issue":"11","key":"2249_CR8","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1164\/rccm.201806-1100OC","volume":"199","author":"PK Schweitzer","year":"2019","unstructured":"Schweitzer PK, Rosenberg R, Zammit GK, et al. Solriamfetol for excessive sleepiness in obstructive sleep apnea (TONES 3): a randomized controlled trial. Am J Respir Crit Care Med. 2019;199(11):1421\u201331. https:\/\/doi.org\/10.1164\/rccm.201806-1100OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2249_CR9","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.chest.2018.11.005","volume":"155","author":"PJ Strollo Jr","year":"2019","unstructured":"Strollo PJ Jr, Hedner J, Collop N, et al. Solriamfetol for the treatment of excessive sleepiness in OSA: a placebo-controlled randomized withdrawal study. Chest. 2019;155(2):364\u201374. https:\/\/doi.org\/10.1016\/j.chest.2018.11.005.","journal-title":"Chest"},{"issue":"2","key":"2249_CR10","doi-asserted-by":"publisher","first-page":"zsz220","DOI":"10.1093\/sleep\/zsz220","volume":"43","author":"A Malhotra","year":"2020","unstructured":"Malhotra A, Shapiro C, Pepin JL, et al. Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea. Sleep. 2020;43(2):zsz220. https:\/\/doi.org\/10.1093\/sleep\/zsz220.","journal-title":"Sleep"},{"key":"2249_CR11","unstructured":"Jazz Pharmaceuticals, Inc. Sunosi\u2122 (solriamfetol) tablets. Prescribing information. 2019. Palo Alto: Jazz Pharmaceuticals, Inc; 2019. https:\/\/sunosihcp.com\/assets\/files\/sunosi.en.uspi.pdf. Accessed 29 July 2022."},{"key":"2249_CR12","unstructured":"Jazz Pharmaceuticals plc. Jazz Pharmaceuticals receives EU marketing authorisation for Sunosi\u00ae (solriamfetol) for excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnea [press release]. 2020. https:\/\/investor.jazzpharma.com\/news-releases\/news-release-details\/jazz-pharmaceuticals-receives-eu-marketing-authorisation-sunosir. Accessed 21 Jan 2020."},{"issue":"3","key":"2249_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ana.25423","volume":"85","author":"MJ Thorpy","year":"2019","unstructured":"Thorpy MJ, Shapiro C, Mayer G, et al. A randomized study of solriamfetol for excessive sleepiness in narcolepsy. Ann Neurol. 2019;85(3):359\u201370. https:\/\/doi.org\/10.1002\/ana.25423.","journal-title":"Ann Neurol"},{"issue":"1","key":"2249_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/nop2.191","volume":"6","author":"TF Eines","year":"2019","unstructured":"Eines TF, Angelo E, Vatne S. Discourse analysis of health providers\u2019 experiences using service design. Nurs Open. 2019;6(1):84\u201392. https:\/\/doi.org\/10.1002\/nop2.191.","journal-title":"Nurs Open"},{"issue":"3","key":"2249_CR15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/cts.12626","volume":"12","author":"RN Schuck","year":"2019","unstructured":"Schuck RN, Pacanowski M, Kim S, Madabushi R, Zineh I. Use of titration as a therapeutic individualization strategy: an analysis of Food and Drug Administration-approved drugs. Clin Transl Sci. 2019;12(3):236\u20139. https:\/\/doi.org\/10.1111\/cts.12626.","journal-title":"Clin Transl Sci"},{"issue":"11","key":"2249_CR16","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1093\/sleep\/32.11.1425","volume":"32","author":"JA Gruner","year":"2009","unstructured":"Gruner JA, Marcy VR, Lin YG, Bozyczko-Coyne D, Marino MJ, Gasior M. The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents. Sleep. 2009;32(11):1425\u201338.","journal-title":"Sleep"},{"issue":"2","key":"2249_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5664\/jcsm.7624","volume":"15","author":"C Stepnowsky","year":"2019","unstructured":"Stepnowsky C, Sarmiento KF, Bujanover S, Villa KF, Li VW, Flores NM. Comorbidities, health-related quality of life, and work productivity among people with obstructive sleep apnea with excessive sleepiness: findings from the 2016 US National Health and Wellness Survey. J Clin Sleep Med. 2019;15(2):235\u201343. https:\/\/doi.org\/10.5664\/jcsm.7624.","journal-title":"J Clin Sleep Med"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02249-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-022-02249-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02249-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T10:07:36Z","timestamp":1661335656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-022-02249-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["2249"],"URL":"https:\/\/doi.org\/10.1007\/s12325-022-02249-4","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,4]]},"assertion":[{"value":"16 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}